Caroline Wheeler‐Jones

ORCID: 0000-0002-6542-7713
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Angiogenesis and VEGF in Cancer
  • Biotin and Related Studies
  • Protein Kinase Regulation and GTPase Signaling
  • Eicosanoids and Hypertension Pharmacology
  • Inflammatory mediators and NSAID effects
  • Cell Adhesion Molecules Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Nitric Oxide and Endothelin Effects
  • Proteoglycans and glycosaminoglycans research
  • Cancer, Lipids, and Metabolism
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cancer, Hypoxia, and Metabolism
  • Platelet Disorders and Treatments
  • Atherosclerosis and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Chronic Kidney Disease and Diabetes
  • Pancreatic function and diabetes
  • Adenosine and Purinergic Signaling
  • Liver Disease and Transplantation
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Pharmacology and Obesity Treatment
  • Estrogen and related hormone effects
  • Hormonal Regulation and Hypertension
  • Metabolism, Diabetes, and Cancer
  • Receptor Mechanisms and Signaling

Royal Veterinary College
2015-2024

University College London
2010-2023

University of Birmingham
2020-2023

Institut de Recherche en Infectiologie de Montpellier
2023

Centre National de la Recherche Scientifique
2023

University of London
2006-2021

Délégation Paris 6
2016-2019

Orthopaedic Hospital
2016-2019

Tsinghua University
2017-2019

Addenbrooke's Hospital
2016

Vascular endothelial growth factor (VEGF) stimulated a time‐ and concentration‐dependent increase in PGI 2 synthesis human umbilical vein cells with mean maximum of 2‐fold above basal levels at 25 ng/ml after 60 min. VEGF also rapidly the release arachidonic acid phosphorylation activation cytosolic phospholipase A (cPLA ). The VEGF‐related factor, placenta (PlGF), had little effect on synthesis, or cPLA activation. PD98059, selective inhibitor MAP kinase kinase, caused complete inhibition...

10.1016/s0014-5793(97)01481-6 article EN FEBS Letters 1997-12-22

Hyperammonemia is a feature of liver failure, which associated with increased risk infection. The aims the present study were to determine in vitro, rats fed an ammoniagenic diet and patients cirrhosis, whether induction hyperammonemia results neutrophil dysfunction. As produces cell swelling, we explored role osmoregulating, p38 mitogen-activated protein kinase (p38(MAPK)) pathway mediating this Neutrophils isolated from blood healthy volunteers incubated either 75 microM ammonia or...

10.1002/hep.22474 article EN Hepatology 2008-06-19

Abstract Communication between endothelial and bone cells is crucial for controlling vascular supply during growth, remodeling, repair but the molecular mechanisms coordinating this intercellular crosstalk remain ill‐defined. We have used primary human rat long bone‐derived osteoblast‐like (HOB LOB) umbilical vein (HUVEC) to interrogate potential autocrine/paracrine role of cell growth factor (VEGF) in osteoblast:endothelial (OB:EC) communication examined whether prostaglandins (PG), known...

10.1002/jcp.21234 article EN Journal of Cellular Physiology 2007-08-08

ABSTRACT Adenosine is released from the myocardium, endothelial cells, and skeletal muscle in ischemia an important regulator of coronary blood flow. We have already shown that acute (2 min) activation A 2a purinoceptors stimulates NO production human fetal umbilical vein cells (1) now report a key role for p42/p44 mitogen‐activated protein kinases (p42/p44 MAPK ) regulation L‐arginine‐nitric oxide (NO) signaling pathway. Expression mRNA ‐, 2b 3 ‐adenosine receptor subtypes was abundant...

10.1096/fasebj.16.12.1584 article EN The FASEB Journal 2002-10-01

Background The adipocyte-derived hormone leptin influences the behaviour of a wide range cell types and is now recognised as pro-angiogenic pro-inflammatory factor. In vasculature, these effects are mediated in part through its direct receptor (ObRb)-driven actions on endothelial cells (ECs) but mechanisms responsible for activities have not been established. this study we sought to more fully define molecular links between inflammatory angiogenic responses leptin-stimulated human ECs....

10.1371/journal.pone.0018823 article EN cc-by PLoS ONE 2011-04-18

Obesity and saturated fatty acid (SFA) treatment are both associated with skeletal muscle insulin resistance (IR) increased macrophage infiltration. However, the relative effects of SFA unsaturated (UFA)-activated macrophages on unknown. Here, were treated palmitic acid, palmitoleic or conditioned medium (CM) C2C12 myotubes investigated. CM from acid-treated J774s (palm-mac-CM) impaired signalling insulin-stimulated glycogen synthesis, reduced Inhibitor κBα phosphorylation p38...

10.1016/j.mce.2014.06.010 article EN cc-by Molecular and Cellular Endocrinology 2014-06-26

Abstract Bone cells' early responses to estrogen and mechanical strain were investigated in the ROS 17/2.8 cell line. Immunoblotting with antiphosphorylated receptor α (ER-α) antibody showed that when these cells exposed for 10 minutes (10−8 M) or a single period of cyclic dynamic (peak 3400 μϵ, 1Hz, 600 cycles), there was an increase intensity 66-kDa band, indicating phosphorylation ser122 amino terminus ER-α. Increased detected within 5 exposure after end strain. Estrogen also activated...

10.1359/jbmr.2001.16.6.1045 article EN Journal of Bone and Mineral Research 2001-06-01

The functional significance of protease-activated receptors (PARs) in endothelial cells is largely undefined, and the intracellular consequences their activation are poorly understood. Here, we show that serine protease thrombin, a PAR-1-selective peptide (TFLLRN), SLIGKV (PAR-2-selective peptide) induce cyclooxygenase-2 (COX-2) protein mRNA expression human without modifying COX-1 expression. COX-2 induction was accompanied by sustained production 6-keto-PGF1alpha, stable hydrolysis product...

10.1074/jbc.m509292200 article EN cc-by Journal of Biological Chemistry 2006-02-09

Arterial medial calcification (AMC) is the deposition of calcium phosphate mineral, often as hydroxyapatite, in layer arteries. AMC shares some similarities to skeletal mineralisation and has been associated with transdifferentiation vascular smooth muscle cells (VSMCs) towards an osteoblast-like phenotype. This study used primary mouse VSMCs calvarial osteoblasts directly compare established widely vitro models bone formation. Significant differences were identified between calcifying...

10.1016/j.yexcr.2019.04.020 article EN cc-by Experimental Cell Research 2019-04-18

Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors used worldwide to manage dyslipidaemia and thus limit the development of atherosclerotic disease its complications. These atheroprotective drugs now known exert pleiotropic actions outside their cholesterol-lowering activity, including altering immune cell function. Macrophages phagocytic leukocytes that play critical functional roles in pathogenesis atherosclerosis directly targeted by statins. Early studies...

10.3390/immuno2020021 article EN cc-by Immuno 2022-04-08

We reported previously that vascular endothelial growth factor (VEGF) stimulates prostacyclin (PGI(2)) production via activation of the extracellular signal-regulated kinase (ERK) cascade. In this paper, we examined role protein C (PKC) in pathway. VEGF-induced PGI(2) generation and arachidonic acid release human umbilical vein cells were inhibited by PKC inhibitors GF109203X calphostin C. VEGF increased activity immunoreactivity PKCdelta, alpha epsilon isoforms particulate fractions cells....

10.1042/0264-6021:3530503 article EN Biochemical Journal 2001-02-01

Up-regulation of proteinase-activated receptor-2 (PAR2) is a factor in number disease states and we have therefore examined the signalling pathways involved expression receptor.

10.1038/sj.bjp.0707150 article EN British Journal of Pharmacology 2007-03-05

Although concern remains about the athero-thrombotic risk posed by cyclo-oxygenase (COX)-2-selective inhibitors, recent data implicates rofecoxib, while celecoxib appears equivalent to NSAIDs naproxen and ibuprofen. We investigated hypothesis that activates AMP kinase (AMPK) signalling enhance vascular endothelial protection. In human arterial venous cells (EC), in contrast ibuprofen naproxen, induced protective protein heme oxygenase-1 (HO-1). Celecoxib derivative 2,5-dimethyl-celecoxib...

10.1038/s41598-018-24548-z article EN cc-by Scientific Reports 2018-04-13

Arterial medial calcification (AMC) is thought to share some outward similarities skeletal mineralization and has been associated with the transdifferentiation of vascular smooth muscle cells (VSMCs) an osteoblast‐like phenotype. ATP UTP have previously shown inhibit bone mineralization. This investigation compared effects extracellular nucleotides on in VSMCs those seen osteoblasts. ATP, ubiquitous inhibitor, pyrophosphate (PP i ), dose dependently inhibited VSMC by ≤85%. Culture calcifying...

10.1002/jcp.26166 article EN Journal of Cellular Physiology 2017-10-04

This study was conducted to determine whether the ERK1/2 family of MAPKs can be modulated by physiological regulators human corpus luteum, and this activation is important for progesterone secretion in granulosa-lutein (hGL) cells. Human LH (hLH), hCG, agents that indirectly elevate cAMP [cholera toxin, forskolin, (Bu)(2)cAMP], time- dose-dependently activated hGL reduced preincubation with PKA inhibitors, including myristoylated PKI, suggesting mediates activation. Two structurally distinct...

10.1210/endo.143.3.8677 article EN Endocrinology 2002-03-01

It is well established that local modification of extracellular matrix (ECM) hyaluronan composition vital in the regulation cell behavior. Indeed, formation articulating chick joint cavities, which requires mechanical stimuli derived from skeletal movement, dependent upon accumulation an ECM rich (HA). However, mechanisms responsible for such precise mechano-dependent behavior and a HA-rich remain undefined. Here we show extracellular-regulated kinase 1/2 (ERK1/2) selectively activated cells...

10.1074/jbc.m414495200 article EN cc-by Journal of Biological Chemistry 2005-01-13
Coming Soon ...